Restrictions on the abortion pill mifepristone resurrected in a federal appeals court decision open the gate for further attacks on scientific expertise from the judiciary, as the Biden administration pleads for the US Supreme Court to weigh in.
The US Court of Appeals for the Fifth Circuit’s ruling pauses a lower court’s decision fully overturning the Food and Drug Administration’s approval of the drug mifepristone used in medication abortions but prevents the pills from being shipped by mail.
On Friday, Supreme Court Justice Samuel Alito temporary halted lower court restrictions on mifepristone.
The administrative stay will be in effect until ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.